Cartalax

Cartalax is a lyophilized research peptide complex composed of short amino acid sequences. Supplied in a 10 mg vial as a dry powder, it is intended for use as a biochemical reference compound in controlled laboratory settings.

Research background

Cartalax has been investigated in experimental models for its interactions with cartilage and connective tissue-related processes. The peptide complex has been studied in relation to extracellular matrix regulation and cell communication within structural tissues. Research interest centres on its potential role in tissue integrity and the regulatory mechanisms governing cartilage structure.

• Studied within models of cartilage and connective tissue processes
• Investigated in relation to extracellular matrix dynamics and tissue regulation
• Examined for its role in cell signalling within structural tissues
• Referenced in experimental research focused on tissue integrity

Reconstitution & handling

Cartalax is supplied as a lyophilized powder and should be reconstituted with an appropriate volume of bacteriostatic water (BAC water) prior to use. Add the BAC water slowly along the inner wall of the vial and gently swirl until the powder is fully dissolved — do not shake. Once reconstituted, keep the solution refrigerated and handle under clean laboratory conditions to maintain integrity.

Storage & stability

Store the lyophilized product in a cool, dry environment, protected from light and moisture. For extended storage, freezing is recommended. Once reconstituted, keep refrigerated and use within a short timeframe consistent with standard peptide handling practice. Avoid repeated freeze-thaw cycles.

A batch-specific Certificate of Analysis (CoA) accompanies every order of Cartalax.